No | Primary DI | Version or Model | Catalog Number | Device Description | Product Code | Product Code Name | Device Class | Brand Name |
---|---|---|---|---|---|---|---|---|
1 | 08426951346462 | 0003310300 | 00003310300 | Avox-4 CO-Oximeter Control, Level 3 | JJY | Multi-analyte controls, all kinds (assayed) | Avox-4 CO-Oximeter Control - L3 | |
2 | 08426951298778 | 00009800015 | 00009800015 | 1. HemosIL Acustar ß2GP1-Domain1 Reagent Cartridge (Cat. No. 000098000162. 1 Re 1. HemosIL Acustar ß2GP1-Domain1 Reagent Cartridge (Cat. No. 000098000162. 1 Resuspension buffer (Cat. No. 00009800019) 3. 1 HemosIL Acustar ß2GP1-Domain1 Calibrator 1 (Cat. No. 00009800017):4. 1 HemosIL Acustar ß2GP1-Domain1 Calibrator 2 (Cat. 00009800018): | MSV | System,test,antibodies,b2 - glycoprotein i (b2 - gpi) | 2 | HemosIL AcuStar Anti-B2GPI Domain 1 |
3 | 08426951293742 | 00044000115 | 00044000115 | GEM ChemSTAT CVP 1, 10 ampoules x 1.8 mL | JJY | Multi-Analyte Controls, All Kinds (Assayed) | GEM ChemSTAT CVP 1 | |
4 | 08426950716419 | 0005312 | 0005312 | Barcode wand | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | Barcode wand |
5 | 08426950497974 | 00000280010 | 00000280010 | ACL TOP 700 | GKP | INSTRUMENT, COAGULATION, AUTOMATED | 2 | ACL TOP 700 |
6 | 08426951027477 | 00055415004XC | 00055415004XC | GEM 5000 BG COOX 150 Test PAK 31 DAY (pH, pCO2, pO2, Hct, tHb, O2Hb, COHb, HHb, GEM 5000 BG COOX 150 Test PAK 31 DAY (pH, pCO2, pO2, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge) | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 5000 PAK BG COOX (150 TEST) |
7 | 08426951027453 | 00055445011XC | 00055445011XC | GEM 5000 BG ISE COOX TBILI 450 Test PAK 31 DAY (pH, pCO2, pO2, Na+, K+, Cl-, Ca GEM 5000 BG ISE COOX TBILI 450 Test PAK 31 DAY (pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Glu, Lac, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2, Tbili Cartridge) | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 5000 PAK BG ISE GL COOX TBILI (450 TEST) |
8 | 08426951027361 | 00055360009XC | 00055360009XC | GEM 5000 BG ISE COOX TBILI 600 Test PAK 21 DAY (pH, pCO2, pO2, Na+, K+, Cl-, Ca+ GEM 5000 BG ISE COOX TBILI 600 Test PAK 21 DAY (pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2, Tbili Cartridge) | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 5000 PAK BG ISE COOX TBILI (600 TEST) |
9 | 08426950927990 | 00000280010R | 00000280010R | ACL TOP 700 (Refurbished) | GKP | INSTRUMENT, COAGULATION, AUTOMATED | 2 | ACL TOP 700 |
10 | 08426950807803 | 00055445009 | 00055445009 | GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Hct, tBili, tHb, O2Hb, C GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Hct, tBili, tHb, O2Hb, COHb, MetHb, HHb, sO2 450 Test 31 Days | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 5000 PAK BG/ISE/COOX/TBILI 450 TEST |
11 | 08426950807797 | 00055445008 | 00055445008 | GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Hct, tHb, O2Hb, COHb, Me GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Hct, tHb, O2Hb, COHb, MetHb, HHb, sO2 450 Test 31 Days | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 5000 PAK BG/ISE/COOX 450 TEST |
12 | 08426950807766 | 00055430011 | 00055430011 | GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Glucose, Lactate, Hct, t GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Glucose, Lactate, Hct, tBili, tHb, O2Hb, COHb, MetHb, HHb, sO2 300 Test 31 Days | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 5000 PAK BG/ISE/GL/COOX/TBILI 300 TEST |
13 | 08426950807728 | 00055430005 | 00055430005 | GEM Premier 5000 PAK pH, pCO2, pO2, Hct, tBili, tHb, O2Hb, COHb, MetHb, HHb, sO2 GEM Premier 5000 PAK pH, pCO2, pO2, Hct, tBili, tHb, O2Hb, COHb, MetHb, HHb, sO2 300 Test 31 Days | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 5000 PAK BG/COOX/TBILI 300 TEST |
14 | 08426950807643 | 00055407511 | 00055407511 | GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Glucose, Lactate, Hct, t GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Glucose, Lactate, Hct, tBili, tHb, O2Hb, COHb, MetHb, HHb, sO2 75 Test 31 Days | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 5000 PAK BG/ISE/GL/COOX/TBILI 75 TEST |
15 | 08426950784050 | 00000280035 | 00000280035 | ACL TOP 750 LAS | GKP | INSTRUMENT, COAGULATION, AUTOMATED | 2 | ACL TOP 750 LAS |
16 | 08426950632870 | 00020301300 | 00020301300 | HemosIL ReadiPlasTin (10 mL) | GJS | TEST, TIME, PROTHROMBIN | 2 | HemosIL ReadiPlasTin (10 mL) |
17 | 08426950580690 | 00020012800 | 00020012800 | HemosIL Factor VIII Deficient Plasma | GJT | PLASMA, COAGULATION FACTOR DEFICIENT | HemosIL Factor VIII Deficient Plasma | |
18 | 08426950574255 | 00097579000 | 00097579000 | HemosIL Chromogenic Optic test 160umol L | JPA | SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES | 2 | Chromogenic Optic 160 umol L |
19 | 08426950573500 | 00020301800 | 00020301800 | HemosIL Q.F.A. Thrombin (Bovine) - 2 mL | GIS | TEST, FIBRINOGEN | HemosIL Q.F.A. Thrombin (Bovine) - 2 mL | |
20 | 08426950566526 | 00020302000 | 00020302000 | HemosIL Protein S Activity | GGP | TEST, QUALITATIVE AND QUANTITATIVE FACTOR DEFICIENCY | 2 | HemosIL Protein S Activity |
21 | 08426950554820 | 00027360008 | 00027360008 | GEM Premier 4000 pH, pCO2, pO2, Na+, K+, Ca++, Cl-, Hct, tHb, O2Hb, COHb, HHb, M GEM Premier 4000 pH, pCO2, pO2, Na+, K+, Ca++, Cl-, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge - 600 Test 21DAY | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM 4000 PAK BG ISE COOX 600 TEST 21 DAY |
22 | 08426950554813 | 00027360004 | 00027360004 | GEM Premier 4000 pH, pCO2, pO2, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge GEM Premier 4000 pH, pCO2, pO2, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge - 600 Test 21DAY | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM 4000 PAK BG COOX 600 TEST 21 DAY |
23 | 08426950554707 | 00027407509 | 00027407509 | GEM Premier 4000 pH, pCO2, pO2, Na+, K+, Ca++, Cl-, Hct, tBili, tHb, O2Hb, COHb, GEM Premier 4000 pH, pCO2, pO2, Na+, K+, Ca++, Cl-, Hct, tBili, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge - 75 Test 30DAY | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM 4000 PAK BG ISE COOX BILI 75 TEST 30 DAY |
24 | 08426950543589 | 00027430008 | 00027430008 | GEM Premier 4000 pH, pCO2, pO2, Na+, K+, Ca++, Cl-, Hct, tHb, O2Hb, COHb, HHb, M GEM Premier 4000 pH, pCO2, pO2, Na+, K+, Ca++, Cl-, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge - 300 Test 30DAY | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM 4000 PAK BG ISE COOX 300 TEST 30 DAY |
25 | 08426950513278 | 00027415004 | 00027415004 | GEM Premier 4000 pH, pCO2, pO2, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge GEM Premier 4000 pH, pCO2, pO2, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge - 150 Test 30DAY | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM 4000 PAK BG COOX 150 TEST 30 DAY |
26 | 08426950511694 | 00026360089 | 00026360089 | GEM Premier 3500 3000 iQM 2WK BG LYTES GL (600 TEST) | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3500 3000 iQM BG LYTES GL (600 TEST) |
27 | 08426950511656 | 00026345084 | 00026345084 | GEM Premier 3500 3000 iQM 3WK BG HCT (450 TEST) | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3500 3000 iQM BG HCT (450 TEST) |
28 | 08426950497035 | 0009802200 | 0009802200 | HemosIL AcuStar System Rinse | JPA | SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES | 2 | HemosIL AcuStar System Rinse |
29 | 08426950497004 | 0009802108 | 0009802108 | HemosIL AcuStar Anti-Cardiolipin IgM Controls | JJX | Single (specified) analyte controls (assayed and unassayed) | 1 | HemosIL AcuStar Anti-Cardiolipin IgM Controls |
30 | 08426950496984 | 0009802016 | 0009802016 | HemosIL AcuStar Anti-B2 Glycoprotein-I IgM | MSV | System,test,antibodies,b2 - glycoprotein i (b2 - gpi) | 2 | HemosIL AcuStar Anti-B2 Glycoprotein-I IgM |
31 | 08426950472490 | 00020300200 | 00020300200 | HemosIL LMW Heparin Controls | KFF | ASSAY, HEPARIN | 2 | HemosIL LMW Heparin Controls |
32 | 08426950453031 | 00020007900 | 00020007900 | HemosIL Homocysteine Controls | JJX | Single (specified) analyte controls (assayed and unassayed) | 1 | HemosIL Homocysteine Controls |
33 | 08426950453154 | 00003315250 | 00003315250 | Multi-4 CO-Oximeter Control, Level 1 | JJY | Multi-analyte controls, all kinds (assayed) | Multi-4 CO-Oximeter Control, Level 1 | |
34 | 08426950446217 | 00024360084 | 00024360084 | GEM Premier 3000 iQM 2WK - BG HCT - 600 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 iQM - BG HCT - 600 Tests |
35 | 08426950446194 | 00027430004 | 00027430004 | GEM Premier 4000 pH, pCO2, pO2, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge GEM Premier 4000 pH, pCO2, pO2, Hct, tHb, O2Hb, COHb, HHb, MetHb, sO2 Cartridge - 300 Test 30DAY | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM 4000 PAK BG COOX 300 TEST 30 DAY |
36 | 08426950088554 | 06260032000 | 06260032000 | GEM Test Citrate PT Cartridges | JPA | SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES | GEM Test Citrate PT Cartridges | |
37 | 08426950088189 | 00024407584 | 00024407584 | GEM Premier 3000 iQM 4WK - BG HCT - 75 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 iQM - BG HCT - 75 Tests |
38 | 08426950088004 | 00024307589 | 00024307589 | GEM Premier 3000 iQM 3WK - BG HCT ELECT. GL - 75 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 iQM - BG HCT ELECT. GL - 75 Tests |
39 | 08426950087960 | 00024307584 | 00024307584 | GEM Premier 3000 iQM 3WK - BG HCT - 75 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 iQM - BG HCT - 75 Tests |
40 | 08426950082538 | 00024345004 | 00024345004 | GEM Premier 3000 3WK - BG HCT - 450 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 - BG HCT - 450 Tests |
41 | 08426950082491 | 00024315009 | 00024315009 | GEM Premier 3000 3WK - BG HCT ELECT. GL - 150 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 - BG HCT ELECT. GL - 150 Tests |
42 | 08426950082484 | 00024315007 | 00024315007 | GEM Premier 3000 3WK - BG HCT ELECT. - 150 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 - BG HCT ELECT. - 150 Tests |
43 | 08426950082453 | 00024360087 | 00024360087 | GEM Premier 3000 iQM 2WK - BG HCT ELECT. - 600 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 iQM - BG HCT ELECT. - 600 Tests |
44 | 08426950082361 | 00024315084 | 00024315084 | GEM Premier 3000 iQM 3WK - BG HCT - 150 Tests | CHL | ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH | 2 | GEM Premier 3000 iQM - BG HCT - 150 Tests |
45 | 08426950075899 | 00029400100 | 00029400100 | Cuvettes (2400 cuvettes) | GKP | INSTRUMENT, COAGULATION, AUTOMATED | Cuvettes (2400 cuvettes) | |
46 | 08426950071068 | 00020003110 | 00020003110 | HemosIL Normal Control ASSAYED | GGN | PLASMA, COAGULATION CONTROL | HemosIL Normal Control ASSAYED | |
47 | 08426950070320 | 00020002700 | 00020002700 | HemosIL Free Protein S | GGP | TEST, QUALITATIVE AND QUANTITATIVE FACTOR DEFICIENCY | 2 | HemosIL Free Protein S |
48 | 08426950010906 | 00003510000 | 00003510000 | Urine Standard, 100 Na 100K | JJO | FLAME EMISSION PHOTOMETER FOR CLINICAL USE | 1 | Urine Standard, 100 Na 100K |
49 | 08426951391615 | 0020500300 | 00020500300 | HemosIL D-Dimer HS 500 (XL) | DAP | Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control | 2 | HemosIL D-Dimer HS 500 |
50 | 08426951346455 | 0003310200 | 00003310200 | Avox-4 CO-Oximeter Control, Level 2 | JJY | Multi-analyte controls, all kinds (assayed) | Avox-4 CO-Oximeter Control - L2 |
No | Primary DI | Version or Model | Catalog Number | Device Description | Brand Name | Organization Name |
---|---|---|---|---|---|---|
1 | 00859394006095 | 90-480 | 90-480 | Protein S Kit 80-160 DET | ThromboTek PSe | R 2 DIAGNOSTICS, INC. |
2 | 00855360006267 | 10826 | 10826 | INTENDED USE An enzyme-linked immunosorbent assay (ELISA) for the quantitative d INTENDED USE An enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Von Willebrand Factor Activity (VWF:Act) in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY OF THE TEST Von Willebrand Factor Antigen (VWF:Ag or Factor VIII-related protein) is a plasma protein found in circulation combined by non-covalent interactions with Factor VIII (FVIII:C), a pro-coagulant protein also known as the anti-hemophilic factor. Deficiency of FVIII causes classic hemophilia while deficiency of VWF causes von Willebrand disease. Von Willebrand Disease is characterized by a deficiency or defect of VWF. Greater than 70% of Von Willebrand disease patients have a type 1 deficiency while approximately 20% have a type II deficiency. The laboratory diagnosis of Von Willebrand disease may require both quantitative and qualitative (functional) determinations to differentiate the two predominant subtypes of the disease, type I and type II. The classification of Von Willebrand disease into subtypes is important in determining the course of clinical treatment. PRINCIPLE OF THE TEST The REAADS VWF:Act assay is a sandwich ELISA. A monoclonal capture antibody specific for the portion of VWF which binds platelets is coated to 96-microwell polystyrene plates. Diluted patient plasma is incubated in the wells. The plates are washed to remove unbound proteins and other plasma molecules. Bound antigen is quantitated using horseradish peroxidase (HRP) conjugated anti-human VWF detection antibody. Following incubation, unbound conjugate is removed by washing. A chromogenic substrate of tetramethylbenzidine (TMB) and hydrogen peroxide (H2O2) is added to develop a colored reaction. The intensity of the color is measured in O.D. units with a spectrophotometer at 450 nm. Patient VWF:Act in relative percent concentration is determined against a curve made from the reference plasma provided with the kit. Refer to Product Package Insert. | REAADS von Willebrand Factor Activity Test Kit | CORGENIX MEDICAL CORPORATION |
3 | 00855360006038 | 034-001 | 034-001 | INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative de INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Von WillebrandFactor Antigen (VWF: Ag) in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY THE TESTVon Willebrand Factor Antigen (VWF:Ag or Factor VIII-related protein) is a plasma protein found incirculation combined by non-covalent interactions with Factor VIII (FVIII:C), a pro-coagulant protein alsoknown as the anti-hemophilic factor. These two proteins show distinct biochemical and functionalproperties as well as different antigenic determinants; their plasma levels may vary independently ofeach other. Deficiency of FVIII causes classic hemophilia while deficiency of VWF causes VonWillebrand disease. VWF:Ag plays a very important role in hemostasis. The prevalence of Von Willebrand disease has been estimated to be 1-3% of thegeneral population. Approximately 80% of Von Willebrand disease patients have a type I deficiency.The laboratory diagnosis of Von Willebrand disease may require both quantitative and qualitative(functional) determinations.PRINCIPLE OF THE TESTREAADS VWF:Ag assay is a sandwich ELISA. A capture antibody specific for human VWF is coated to96-microwell polystyrene plates. Diluted patient plasma is incubated in the wells, allowing any availableVWF:Ag to bind to the anti-human VWF antibody on the microwell surface. The plates are washed toremove unbound proteins and other plasma molecules. Bound VWF:Ag is quantitated using horseradishperoxidase (HRP) conjugated anti-human VWF detection antibody. Following incubation, unboundconjugate is removed by washing. A chromogenic substrate of tetramethylbenzidine (TMB) and hydrogenperoxide (H2O2) is added to develop a colored reaction. The intensity of the color is measured in opticaldensity (O.D.) units with a spectrophotometer at 450nm. Patient VWF:Ag in relative percentconcentration is determined against a curve made from the reference plasma provided with the kit. Refer to product package insert. | REAADS von Willebrand Factor Antigen Test Kit | CORGENIX MEDICAL CORPORATION |
4 | 00855360006021 | 035-001 | 035-001 | INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative de INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Protein C Antigen in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY AND EXPLANATION OF THE TESTProtein C deficiency, either congenital or acquired, may lead to serious thrombotic events such as thrombophlebitis, deep vein thrombosis, or pulmonary embolism. Patients with a congenital heterozygous deficiency may present with venous thrombosis in young adulthood, while patients with the rare homozygous deficiency present with massive thrombosis (purpura fulminans) during the neonatal period. The prevalence of Protein C deficiency in the general population has been estimated at 1 in 300. In younger patients (<40-45 years) with recurrent venous thrombosis, the frequency of Protein C deficiencies may be as high as 10 to 15%. A decreased Protein C activity in plasma may be the result of low concentrations and function (type I) or only low function (type II).PRINCIPLE OF THE TESTThe Protein C Antigen assay is a sandwich ELISA. A capture antibody specific for human Protein C is coated to 96-microwell polystyrene plates. Diluted patient plasma is incubated in the wells, allowing any available Protein C to bind to the anti-human Protein C antibody on the microwell surface. The plates are washed to remove unbound proteins and other plasma molecules. Bound Protein C is quantitated using horseradish peroxidase (HRP) conjugated anti-human Protein C detection antibody. Following incubation, unbound conjugate is removed by washing. A chromogenic substrate of tetramethylbenzidine (TMB) and hydrogen peroxide (H2O2) is added to develop a colored reaction. The intensity of the color is measured in optical density (O.D.) units with a spectrophotometer at 450nm. Protein C Antigen relative percent concentrations in patient plasma are determined against a curve prepared from the reference plasma provided with the kit.Refer to Product Package Insert. | REAADS Protein C Test Kit | CORGENIX MEDICAL CORPORATION |
5 | 00855360006014 | 051-001 | 051-001 | INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative de INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Free Protein S Antigen in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY AND EXPLANATION OF THE PROTEIN S TESTProtein S is a vitamin K-dependent protein synthesized in the liver, vascular endothelium, and megakaryocytes, which plays an important physiologic role in the Protein C Anticoagulant System. This anticoagulant system is one of the major regulators of hemostasis by inhibiting clot formation and by promoting fibrinolysis. Protein S functions as a cofactor for activated Protein C on the vascular membrane to facilitate the degradation of clotting factors Va and VIIIa, down-regulating clot formation. In normal plasma approximately 40% of Protein S circulates as a free molecule, while 60% is complexed with C4b, a plasma protein of the classical complement pathway. Only Free Protein S is functionally active and able to bind to activated Protein C, while the complexed form of Protein S is not.Protein S deficiency, either congenital or acquired, may lead to serious thrombotic events such as thrombophlebitis, deep vein thrombosis, or pulmonary embolism. The prevalence of Protein S deficiency has been estimated to be less than 1 case per 300 in the general population. Two-thirds of patients with a congenital deficiency of Protein S (levels less than 50% of normal) may present with venous thrombosis in young adulthood. In young patients (<35 years) with a history of thrombosis, the prevalence may be as high as 15 to 18%. Acquired Protein S deficiency may be seen during pregnancy, oral contraceptive or oral anticoagulant therapy, liver disease, diabetes mellitus, postoperative complications, septicemia, and various inflammatory syndromes. A decreased Protein S activity in plasma may be the result of low concentrations or abnormal function of the Protein S molecule.Refer to Product Package Insert. | REAADS Monoclonal Free Protein S Antigen | CORGENIX MEDICAL CORPORATION |
6 | 00855360006007 | 036-001 | 036-001 | INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative de INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Total and Free Protein S Antigen in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY AND EXPLANATION OF THE PROTEIN S TESTProtein S is a vitamin K-dependent protein synthesized in the liver, vascular endothelium, and megakaryocytes, which plays an important physiologic role in the Protein C Anticoagulant System. This anticoagulant system is one of the major regulators of hemostasis by inhibiting clot formation and by promoting fibrinolysis. Protein S functions as a cofactor for activated Protein C on the vascular membrane to facilitate the degradation of clotting factors Va and VIIIa, downregulating clot formation. In normal plasma approximately 40% of Protein S circulates as a free molecule, while 60% is complexed with C4b, a plasma protein of the classical complement pathway. Only Free Protein S is functionally active and able to bind to activated Protein C, while the complexed form of Protein S is not.Protein S deficiency, either congenital or acquired, may lead to serious thrombotic events such as thrombophlebitis, deep vein thrombosis, or pulmonary embolism. The prevalence of Protein S deficiency has been estimated to be less than 1 case per 300 in the general population. Two-thirds of patients with a congenital deficiency of Protein S (levels less than 50% of normal) may present with venous thrombosis in young adulthood. In young patients (<35 years) with a history of thrombosis, the prevalence may be as high as 15 to 18%.7 Acquired Protein S deficiency may be seen during pregnancy, oral contraceptive or oral anticoagulant therapy, liver disease, diabetes mellitus, postoperative complications, septicemia and various inflammatory syndromes.8 A decreased Protein S activity in plasma may be the result of low concentrations or abnormal function of the Protein S molecule.Refer to Product Package Insert. | REAADS Protein S Antigen Test kit | CORGENIX MEDICAL CORPORATION |
7 | 00850201006161 | ACC-45 | ACC-45 | ACTICLOT C KIT | BIOMEDICA ADI INC. | |
8 | 00850201006154 | 843L | 843L | ACTICLOT PROTEIN S | BIOMEDICA ADI INC. | |
9 | 00850201006109 | 101201 | 101201 | SPECTROLYSE PAI-1 | BIOMEDICA ADI INC. | |
10 | 00850201006093 | 885 | 885 | IMUBIND vWF ACTIVITY ELISA | BIOMEDICA ADI INC. | |
11 | 00850201006048 | 822 | 822 | IMUBIND PLASMA PAI-1 ELISA | BIOMEDICA ADI INC. | |
12 | 00843876000558 | CCCF08 | CCCF08 | CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantita CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantitative determination of factor VIII activity in 3.2% citrated human plasma. It is intended to be used in identifying factor VIII deficiency and as an aid in the management of hemophilia A in individuals aged 2 years and older. For in vitro diagnostic use | CRYOcheck Factor VIII Chromogenic | PRECISION BIOLOGIC INC |
13 | 00843876000503 | CCIK08 | The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction with a factor VIII activity assay to enable performance of a modified Nijmegen-Bethesda assay using 3.2% citrated human plasma. It enables the determination of a functional FVIII inhibitor titer to aid in the clinical management of congenital hemophilia A in individuals aged 2 years and older. | CRYOcheck™ FVIII Inhibitor Kit | PRECISION BIOLOGIC INC | |
14 | 00843876000497 | CSD | C & S Diluent | PRECISION BIOLOGIC INC | ||
15 | 00843876000428 | CCS-30 | CRYOcheck™ Clot S™ | PRECISION BIOLOGIC INC | ||
16 | 00843876000411 | CCS-15 | CRYOcheck™ Clot S™ | PRECISION BIOLOGIC INC | ||
17 | 00843876000404 | CCC-30 | CRYOcheck™ Clot C™ | PRECISION BIOLOGIC INC | ||
18 | 00843876000398 | CCC-15 | CRYOcheck™ Clot C™ | PRECISION BIOLOGIC INC | ||
19 | 00842768039522 | 10873458 | OPGL07 | For the quantitative determination of free protein S antigen in human plasma col For the quantitative determination of free protein S antigen in human plasma collected from venous blood samplesin 3.2 % sodium citrate tubes on the BCS XP System, the SYSMEX CS-2500 analyzer and the SYSMEX CS-5100 analyzer. | INNOVANCE Free PS Ag | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
20 | 00842768038211 | 10714565 | OUBD39 | Determination of ristocetin co-factor activity of von Willebrand factor in human Determination of ristocetin co-factor activity of von Willebrand factor in human plasma through platelet agglutination | BC von Willebrand Reagent | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
21 | 00842768011917 | 10446500 | OUVV17 | Quantative determination of protein C activity as an aid in the diagnosis of inh Quantative determination of protein C activity as an aid in the diagnosis of inherited and acquired deficiencies | Berichrom® Protein C | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
22 | 00842768011900 | 10446499 | OUVV15 | Quantative determination of protein C activity as an aid in the diagnosis of inh Quantative determination of protein C activity as an aid in the diagnosis of inherited and acquired deficiencies | Berichrom® Protein C | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
23 | 00842768011160 | 10446427 | OUBU15 | Quantative determination of a2-antiplasmin activity as an aid in the diagnosis o Quantative determination of a2-antiplasmin activity as an aid in the diagnosis of inherited or acquired deficiencies and in management of fibrinolytic therapy | Berichrom® a2-Antiplasmin | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
24 | 00842768008641 | 10446185 | OQYG11 | Coagulation test for the quantitative determination of protein C activity in human plasma | Protein C Reagent | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
25 | 00842768006678 | 10445968 | OPAP03 | Determination of the functional activity of protein S in human plasma | Protein S Ac | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
26 | 00842768004032 | 10445729 | B4238-40 | Determination of Factor VIII (antihemophilic factor) activity in human plasma | Factor VIII Chromogenic Assay | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
27 | 00811476010291 | 299-3 | vW Reference Plasma Normal | Chrono-log | CHRONO-LOG CORP | |
28 | 00811476010161 | 299 | Ristocetin Cofactor Assay Kit | Chrono-log | CHRONO-LOG CORP | |
29 | 00811476010130 | 299-5 | Tris Buffered Saline | Chrono-log | CHRONO-LOG CORP | |
30 | 00811476010123 | 299-2 | Lyophilized Human Platelets 6mL, TBS 12mL | Chrono-log | CHRONO-LOG CORP | |
31 | 00811476010017 | 299-4 | vW Reference Plasma Deficient | Chrono-log | CHRONO-LOG CORP | |
32 | 00811476010000 | 299-1 | Ristocetin 7.5 mg/Vial | Chrono-log | CHRONO-LOG CORP | |
33 | 13607450007258 | 00725 | STA® - Deficient VIII | DIAGNOSTICA STAGO | ||
34 | 10888234500346 | 403596 | 403596 | For Use with Factor VIII Antibody Screen | Positive Control | IMMUCOR GTI DIAGNOSTICS, INC. |
35 | 10888234500339 | 403593 | 403593 | For Use with Factor VIII Antibody Screen | Negative Control | IMMUCOR GTI DIAGNOSTICS, INC. |
36 | 10888234500322 | 403591 | 403591 | For Use with Factor VIII Antibody Screen | Kit Control | IMMUCOR GTI DIAGNOSTICS, INC. |
37 | 10888234500001 | F8S | F8S | The Factor VIII Antibody Screen is a qualitative solid phase enzyme linked immun The Factor VIII Antibody Screen is a qualitative solid phase enzyme linked immunosorbent assay (ELISA) designed to detect reactive with recombinant human factor VIII (FVIII) in human serum and plasma. | Factor VIII Antibody Screen | IMMUCOR GTI DIAGNOSTICS, INC. |
38 | 10629009020009 | FIX-AG | 96 Test enzyme immunoassay kit for the determination of FIX Antigen | VisuLize Factor FIX Antigen Kit | AFFINITY BIOLOGICALS INC | |
39 | 10629009010000 | FVIII-AG | 96 Test enzyme immunoassay kit for the determination of FVIII Antigen | VisuLize Factor FVIII Antigen Kit | AFFINITY BIOLOGICALS INC | |
40 | M52553730 | 5373 | Ristocetin Cofactor Abnormal Control Plasma | HELENA LABORATORIES CORPORATION | ||
41 | M52553720 | 5372 | Helena Ristocetin - 10 mg/mL | HELENA LABORATORIES CORPORATION | ||
42 | M52553710 | 5371 | Lyophilized Platelets | HELENA LABORATORIES CORPORATION | ||
43 | M52553700 | 5370 | Ristocetin Cofactor Assay Kit | HELENA LABORATORIES CORPORATION | ||
44 | M52553650 | 5365 | Tris-Buffered Saline | HELENA LABORATORIES CORPORATION | ||
45 | M52553630 | 5363 | Free Protein S Reagent | HELENA LABORATORIES CORPORATION | ||
46 | M52553610 | 5361 | von Willebrand Factor Antigen Rocket Kit | HELENA LABORATORIES CORPORATION | ||
47 | M52553600 | 5360 | Rocket Stain | HELENA LABORATORIES CORPORATION | ||
48 | M52553590 | 5359 | Protein S Antigen Rocket Kit | HELENA LABORATORIES CORPORATION | ||
49 | M52553580 | 5358 | Tris-Tricine Buffer | HELENA LABORATORIES CORPORATION | ||
50 | M52553570 | 5357 | Protein C Antigen Rocket Kit | HELENA LABORATORIES CORPORATION |